跳至主要内容
临床试验/NCT04479826
NCT04479826已完成不适用

Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2020年7月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
1
主要终点
Time in ranges

研究概览

简要总结

The study will follow participants for the periods of 3 months while using an advanced hybrid closed loop algorithm in free living conditions . Each period will have a different meal handling protocols. The objective is to identify the mitigation of the algorithm with different meal handling approaches.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subject is 20 to 70 years of age at time of screening
  • •Subject's weight is between 50 and 120 kg
  • •A clinical diagnosis of Type 1 diabetes as determined by the Investigator for a minimum of 36 months prior to enrollment
  • •Subject has ongoing use of an insulin pump and rtCGM ≥ 6 months prior to screening
  • •Subject has an A1C value ≤ 10.0% demonstrated at the time of enrollment.
  • •Subject uses a rapid-acting analogue insulin in his/her pump
  • •Patient is willing to undergo all study procedures
  • •English proficiency
  • •Minimum daily insulin requirement (Total Daily Dose) of greater than or equal to 8 units

排除标准

  • •Female subject who has a positive serum pregnancy screening test, or who plans to become pregnant during the course of the study
  • •Subject has unresolved adverse skin condition, or unable to tolerate tape adhesive, in the area of sensor placement or device replacement (e.g., psoriasis, rash, Staphylococcus infection)
  • •Subject has a history of hypoglycemic seizure or hypoglycemic coma within the past 12 months
  • •Subjects currently taking adjunct therapy with SGLT2-inhibitors, GLP-1 mimetics, Amylin.
  • •Subject has a history of seizure disorder unrelated to diabetes within the past 12 months
  • •Gastroparesis, uncontrolled thyroid disorder, Addison dis. , Pituitary insufficiency
  • •Subject has a history of myocardial infarction, unstable angina, coronary artery bypass surgery, coronary artery stenting, transient ischemic attack (TIA), cerebrovascular accident (CVA), congestive heart failure, ventricular rhythm disturbances, or thromboembolic disease within the past 6 months
  • •Subject has a presence of a cardiac pacemaker or any other device that may be sensitive to radio frequency telemetry
  • •Subject has any condition, including screening lab values that in the opinion of the Investigator may preclude him/her from participating in the study and completing study related procedures
  • •Subject is actively participating in other investigational study (drug or device)
  • •Subjects who consume alcohol daily

结局指标

主要结局

Time in ranges

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Prof. Amir Tirosh

Clinical Professor

Sheba Medical Center

研究点 (1)

Loading locations...

相似试验